Cargando…
Tuberculosis and COVID-19 in India: Challenges and opportunities
Autores principales: | Prasad, Rajendra, Singh, Abhijeet, Gupta, Nikhil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507925/ https://www.ncbi.nlm.nih.gov/pubmed/32643635 http://dx.doi.org/10.4103/lungindia.lungindia_260_20 |
Ejemplares similares
-
Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
por: Prasad, Rajendra, et al.
Publicado: (2022) -
Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management
por: Prasad, Rajendra, et al.
Publicado: (2017) -
2025 too short time to eliminate tuberculosis from India
por: Prasad, Rajendra, et al.
Publicado: (2017) -
Cancer research in India: Challenges & opportunities
por: Singh, Mayank, et al.
Publicado: (2018) -
Ending tuberculosis in India: A political challenge & an opportunity
por: Dias, Hannah Monica Yesudian, et al.
Publicado: (2018)